Visual Abstract

Little is known about how arterial stiffness and HRV progress in young adults with youth-onset T2D. We examined changes in pulse wave velocity (PWV), augmentation index (AIx), brachial distensibility and HRV over 5-years in young adults with T2D (n=304, 34% male, first assessment at mean age 21 years, mean diabetes duration 8 years) who participated in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) trial. Changes by sex, race/ethnicity, and the risk factors associated with the changes in arterial stiffness and HRV were assessed. PWV carotid-femoral, AIx and HRV worsened over 5-years (p<0.0001), Table. There were no differences in the 5-year change by race/ethnicity. In multivariable models, female sex (β=2.9, p=0.03) and mean arterial pressure (β=1.9 per 10 mmHg, p< 0.001) related to greater worsening in AIx. Mean arterial pressure related to PWV carotid-femoral (β=0.4 per 10 mmHg, p<0.0001). Higher time-weighted mean HbA1c, a measure of cumulative glycemic exposure, was related to worsening of both PWV carotid-femoral and HRV (β=0.1, p=0.03 and β=-3.8, p<0.0001, per 1% respectively). Targeting improvements in blood pressure and glycemic control may favorably influence the progression of arterial stiffness and HRV in T2D.

Disclosure

A. S. Shah: None. S. A. Arslanian: Advisory Panel; Self; Eli Lilly and Company, Novo Nordisk, Other Relationship; Self; AstraZeneca, Research Support; Self; Eli Lilly and Company, Novo Nordisk. E. M. Urbina: None. L. El ghormli: None. S. Gidding: None. K. S. Hughan: None. L. E. Katz: None. D. Koren: None. J. B. Tryggestad: None. F. Bacha: None. B. H. Braffett: None.

Funding

National Institute of Diabetes and Digestive and Kidney Diseases (U01DK61212, U01DK61230, U01DK61239, U01DK61242, U01DK61254)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.